PHARMASSISTANCE
ActiveSummary
PHARMASSISTANCE has been active since 1993 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€368,433) and a net result of -€1,501. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 5% of 10,739 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Articles of association
What the company does
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- PHARMASSISTANCE
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, bestuursorgaan” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Hoogstens zes jaar, te allen tijde en zonder opgave van redenen met onmiddellijke ingang door algemene vergadering” (deed in Dutch)
Oversight and winding up
- Dissolution ruleWhen and by whom the company can be dissolved.
- “Zoals inzake statutenwijziging, algemene vergadering” (deed in Dutch)